Inspire Medical Systems Net Income 2017-2025 | INSP

Inspire Medical Systems net income from 2017 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Inspire Medical Systems Annual Net Income
(Millions of US $)
2024 $54
2023 $-21
2022 $-45
2021 $-42
2020 $-57
2019 $-33
2018 $-22
2017 $-18
2016 $-19
Inspire Medical Systems Quarterly Net Income
(Millions of US $)
2025-03-31 $3
2024-12-31 $35
2024-09-30 $18
2024-06-30 $10
2024-03-31 $-10
2023-12-31 $15
2023-09-30 $-9
2023-06-30 $-12
2023-03-31 $-15
2022-12-31 $3
2022-09-30 $-17
2022-06-30 $-14
2022-03-31 $-17
2021-12-31 $-2
2021-09-30 $-10
2021-06-30 $-13
2021-03-31 $-16
2020-12-31 $-7
2020-09-30 $-10
2020-06-30 $-23
2020-03-31 $-16
2019-12-31 $-9
2019-09-30 $-8
2019-06-30 $-8
2019-03-31 $-8
2018-12-31 $-5
2018-09-30 $-5
2018-06-30 $-6
2018-03-31 $-7
2017-12-31 $-4
2017-09-30 $-4
2017-06-30 $-5
2017-03-31 $-4
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $3.751B $0.803B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.172B 58.74
Hims & Hers Health (HIMS) United States $12.418B 129.02
Tempus AI (TEM) United States $12.340B 0.00
IRhythm Technologies (IRTC) United States $4.592B 0.00
Privia Health (PRVA) United States $2.761B 188.75
Hinge Health (HNGE) United States $2.719B 0.00
Enovis (ENOV) United States $1.822B 10.16
Schrodinger (SDGR) United States $1.572B 0.00
Phreesia (PHR) United States $1.547B 0.00
Clover Health Investments (CLOV) United States $1.468B 0.00
Azenta (AZTA) United States $1.401B 65.11
Omnicell (OMCL) United States $1.370B 24.17
10x Genomics (TXG) United States $1.282B 0.00
Fulgent Genetics (FLGT) United States $0.630B 0.00
Claritev (CTEV) United States $0.610B 0.00
Butterfly Network (BFLY) United States $0.569B 0.00
Veradigm (MDRX) United States $0.487B 0.00
Talkspace (TALK) United States $0.477B 142.50
Standard BioTools (LAB) United States $0.399B 0.00
Outset Medical (OM) United States $0.354B 0.00
TruBridge (TBRG) United States $0.347B 769.00
Health Catalyst (HCAT) United States $0.264B 0.00
Nyxoah SA (NYXH) Belgium $0.257B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.149B 0.00
EUDA Health Holdings (EUDA) Singapore $0.138B 0.00
Pulmonx (LUNG) United States $0.122B 0.00
American Well (AMWL) United States $0.106B 0.00
MDxHealth SA (MDXH) Belgium $0.095B 0.00
CareCloud (CCLD) United States $0.088B 3.34
111 (YI) China $0.070B 0.00
HeartBeam (BEAT) United States $0.051B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
Zepp Health (ZEPP) Netherlands $0.033B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.032B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00